1-4 of 4
Philip Z. Brohawn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study

Han Si, Michael Kuziora, Katie J. Quinn, Elena Helman, Jiabu Ye, Feng Liu, Urban Scheuring, Solange Peters, Naiyer A. Rizvi, Philip Z. Brohawn, Koustubh Ranade, Brandon W. Higgs, Kimberly C. Banks, Vikram K. Chand, Rajiv Raja
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (6): 1631–1640.
DOI: https://doi.org/10.1158/1078-0432.CCR-20-3771
Published: 15 March 2021
View article
PDF
Includes: Supplementary data
Journal Articles

Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

Ronan J. Kelly, Jeeyun Lee, Yung-Jue Bang, Khaldoun Almhanna, Mariela Blum-Murphy, Daniel V.T. Catenacci, Hyun Cheol Chung, Zev A. Wainberg, Michael K. Gibson, Keun-Wook Lee, Johanna C. Bendell, Crystal S. Denlinger, Cheng Ean Chee, Takeshi Omori, Rom Leidner, Heinz-Josef Lenz, Yee Chao, Marlon C. Rebelatto, Philip Z. Brohawn, Peng He, Jennifer McDevitt, Siddharth Sheth, Judson M. Englert, Geoffrey Y. Ku
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (4): 846–854.
DOI: https://doi.org/10.1158/1078-0432.CCR-19-2443
Published: 14 February 2020
View article
PDF
Includes: Supplementary data
Journal Articles

Early Reduction in ctDNA Predicts Survival in Patients with Lung and Bladder Cancer Treated with Durvalumab

Rajiv Raja, Michael Kuziora, Philip Z. Brohawn, Brandon W. Higgs, Ashok Gupta, Phillip A. Dennis, Koustubh Ranade
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (24): 6212–6222.
DOI: https://doi.org/10.1158/1078-0432.CCR-18-0386
Published: 13 December 2018
View article
PDF
Includes: Supplementary data
Journal Articles

Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non–Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab

Brandon W. Higgs, Christopher A. Morehouse, Katie Streicher, Philip Z. Brohawn, Fernanda Pilataxi, Ashok Gupta, Koustubh Ranade
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (16): 3857–3866.
DOI: https://doi.org/10.1158/1078-0432.CCR-17-3451
Published: 14 August 2018
View article
PDF
Includes: Supplementary data